Marea Therapeutics
PrivateLast Round
Series B
Jun 18, 2024
Total Funding Raised
$190M
Company Overview
Marea Therapeutics is a biotechnology company that develops first-in-class therapies for cardioendocrine diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marea Therapeutics Comparables
Compare Marea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 76% | |
| Amgen | 73% | |
| Eli Lilly and Company | 73% | |
Marea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2024 |
Key People
Founding team and executive leadership
Marea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series B |
| Omega Funds | Series B |
| Forbion | Series B |
| Perceptive Advisors | Series B |
| Citadel | Series B |
| venBio | Series B |
| Alpha Wave Global | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Third asset in research discovery, with DC nomination expected next year.
- Mar 4, 2026
Second asset, MAR002, enters Phase 1 for acromegaly.
Marea Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Marea Therapeutics's valuation, stock price, and market status.